Complement components and their autoantibodies

Applied Biochemistry and Biotechnology - Part B Molecular Biotechnology

Volumn 23, Issue 3, 2003, Pages 259-270

  Norsworthy, P ^b   Davies, K A ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

Autoantibodies; Autoimmunity; Complement components

Indexed keywords

ANTIGEN; AUTOANTIBODY; COMPLEMENT; COMPLEMENT COMPONENT C1; COMPLEMENT INHIBITOR; NEPHRITIC FACTOR;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY REACTION; ARTICLE; AUTOIMMUNITY; COMPLEMENT SYSTEM; CONTROLLED STUDY; HUMAN; IMMUNOPATHOGENESIS;

ALGORITHMS; AUTOANTIBODIES; AUTOIMMUNITY; BLOTTING, WESTERN; CARRIER PROTEINS; COMPLEMENT C1 INACTIVATOR PROTEINS; COMPLEMENT C3 NEPHRITIC FACTOR; COMPLEMENT SYSTEM PROTEINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MOLECULAR PROBE TECHNIQUES; PROTEINS; SERPINS;

EID: 0346035029     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1385/MB:23:3:259     Document Type: Article

References (42)

1. Antes, U., Heinz, H. P., and Loos, M. (1988) Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus. Arthritis Rheum. 31, 457-464.
2. Golan, M. D., Burger, R., and Loos, M. (1982) Conformational changes in C1q after binding to immune complexes: detection of neoantigens with monoclonal antibodies. J. Immunol. 129, 445-447.
3. Hoekzema, R., Martens, M., Brouwer, M. C., and Hack, C. E. (1988) The distortive mechanism for the activation of complement component C1 supported by studies with a monoclonal antibody against the "arms" of C1q. Mol. Immunol. 25, 485-494.
4. Wener, M. H., Uwatoko, S., and Mannik, M. (1989) Antibodies to the collagen-like region of C1q in sera of patients with autoimmune rheumatic diseases. Arthritis Rheum. 32, 544-551.
5. Prada, A. E. and Strife, C. F. (1992) IgG subclass restriction of autoantibody to solid-phase C1q in membranoproliferative and lupus glomerulonephritis. Clin. Immunol. Immunopathol. 63, 84-88.
6. Strife, C. F., Leahy, A. E., and West, C. D. (1989) Antibody to a cryptic, solid phase C1Q antigen in membranoproliferative nephritis. Kidney Int. 35, 836-842.
7. Siegert, C. E., Daha, M. R., van der Voort, E. A., and Breedveld, F. C. (1990) IgG and IgA antibodies to the collagen-like region of C1q in rheumatoid vasculitis. Arthritis Rheum. 33, 1646-1654.
8. Marder, R. J., Potempa, L. A., Jones, J. V., Toriumi, D., Schmid, F. R., and Gewurz, H. (1984) Assay, purification and further characterization of 7S C1q-precipitins (C1q-p) in hypocomplementemic vasculitis urticaria syndrome and systemic lupus erythematosus. Acta. Pathol. Microbiol. Immunol. Scand. Suppl. 284, 25-34.
9. Wisnieski, J. J. and Naff, G. B. (1989) Serum IgG antibodies to C1q in hypocomplementemic urticarial vasculitis syndrome. Arthritis. Rheum. 32, 1119-1127.
10. Siegert, C. E., Daha, M. R., Halma, C., van der Voort, E. A., and Breedveld, F. C. (1992) IgG and IgA autoantibodies to C1q in systemic and renal diseases. Clin. Exp. Rheumatol. 10, 19-23.
11. Coremans, I. E., Daha, M. R., van der Voort, E. A., Muizert, Y., Halma, C., and Breedveld, F. C. (1992) Antibodies against C1q in anti-glomerular basement membrane nephritis. Clin. Exp. Immunol. 87, 256-260.
12. Siegert, C., Daha, M., Westedt, M. L., van der Voort, E., and Breedveld, F. (1991) IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus. J. Rheumatol. 18, 230-234.
13. Uwatoko, S., Aotsuka, S., Okawa, M., et al., (1987) C1q solid-phase radioimmunoassay: evidence for detection of antibody directed against the collagen-like region of C1q in sera from patients with systemic lupus erythematosus. Clin. Exp. Immunol. 69, 98-106.
14. Siegert, C. E., Daha, M. R., Tseng, C. M., Coremans, I. E., van Es, L. A., and Breedveld, F. C. (1993) Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus. Ann. Rheum. Dis. 52, 851-856.
15. Coremans, I. E., Spronk, P. E., Bootsma, H., Daha, M. R., van der Voort, E. A., Kater, L., Breedveld, F. C., and Kallenberg, C. G. (1995) Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus. Am. J. Kidney Dis. 26, 595-601.
16. Norsworthy, P., Theodoridis, E., Botto, M., et al. (1998) Over-representation of the FcγRIIA R131/131 genotype in caucasoid SLE patients with auto-antibodies to C1q and glomerulonephritis. Arthritis Rheum. 42, 1828-1832.
17. Wisnieski, J. J., Baer, A. N., Christensen, J., et al. (1995) Hypocomplementemic urticarial vasculitis syndrome. Clinical and serologic findings in 18 patients. Medicine Baltimore 74, 24-41.
18. Davies, A. E. (1988) C1 inhibitor and hereditary angioneurotic edema. Ann. Rev. Immunol. 6, 595-628.
19. Cicardi, M., Beretta, A., Colombo, M., Gioffre, D., Cugno, M., and Agostoni, A. (1996) Relevance of lymphoproliferative disorders and of anti-C1 inhibitor autoantibodies in acquired angio-oedema. Clin. Exp. Immunol 106, 475-480.
20. Geha, R. S., Quinti, I., Austen, K. F., Cicardi, M., Sheffer, A., and Rosen, F. S. (1985) Acquired C1-inhibitor deficiency associated with antiidiotypic antibody to monoclonal immunoglobulins. N. Engl. J. Med. 312, 534-540.
21. Malbran, A., Hammer, C. H., Frank, M. M., and Fries, L. F. (1988) Acquired angioedema: observations on the mechanism of action of autoantibodies directed against C1 esterase inhibitor. J. Allergy Clin. Immunol. 81, 1199-1204.
22. Mandle, R., Baron, C., Roux, E., et al. (1994) Acquired C1 inhibitor deficiency as a result of an autoantibody to the reactive center region of C1 inhibitor. J. Immunol. 152, 4680-4685.
23. He, S., Tsang, S., North, J., Chohan, N., Sim, R. B., and Whaley, K. (1996) Epitope mapping of C1 inhibitor autoantibodies from patients with acquired C1 Inhibitor deficiency. J. Immunol. 156, 2009-2013.
24. Alsenz, J., Bork, K., and Loos, M. (1987) Autoantibody-mediated acquired deficiency of C1 inhibitor. N. Eng. J. Med. 316, 1360-1366.
25. Spitzer, R. E., Vallota, E. H., Forristal, J., et al. (1969) Serum C'3 lytic system in patients with glomerulonephritis. Science 164, 436-437.
26. Peters, D. K., Charlesworth, J. A., Sissons, J. G., et al. (1973) Mesangiocapillary nephritis, partial lipodystrophy, and hypocomplementaemia. Lancet 2, 535-538.
27. Vallota, E. H., Forristal, J., Spitzer, R. E., Davis, N. C., and West, C. D. (1970) Characteristics of a noncomplement-dependent C3-reactive complex formed form factors in nephritic and normal serum. J. Exp. Med. 131, 1306-1324.
28. Vallota, E. H., Forristal, J., Spitzer, R. E., Davis, N C., and West, C. D. (1971) Continuing C3 breakdown after bilateral nephrectomy in patients with membrano-proliferative glomerulonephritis. J. Clin. Invest. 50, 552-558.
29. Daha, M. R., Fearon, D. T., and Austen, K. F. (1976) C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase. J. Immunol. 116, 1-7.
30. Weiler, J. M., Daha, M. R., Austen, K. F., and Fearon, D. T. (1976). Control of the amplification convertase of complement by the plasma protein beta1H. Proc. Natl. Acad. Sci. USA 73, 3268-3272.
31. Tanuma, Y., Ohi, H., and Hatano, M. (1990). Two types of C3 nephritic factor: properdin-dependent C3NeF and properdin-independent C3NeF. Clin. Immunol. Immunopathol. 56, 226-238.
32. Ohi, H., Watanabe, S., Fujita, T., and Yasugi, T. (1992) Significance of C3 nephritic factor (C3NeF) in non-hypocomplementaemic serum with membranoproliferative glomerulonephritis (MPGN). Clin. Exp. Immunol. 89, 479-484.
33. Daha, M. R. and van Es, L. A. (1981) Stabilization of homologous and heterologous cell-bound amplification convertases, C3bBb, by C3 nephritic factor. Immunology 43, 33-38.
34. Halbwachs, L., Leveille, M., Lesavre, P., Wattel, S., and Leibowitch, J. (1980) Nephritic factor of the classical pathway of complement: immunoglobulin G autoantibody directed against the classical pathway C3 convetase enzyme. J. Clin. Invest. 65, 1249-1256.
35. Daha, M. R., Hazevoet, H. M., Vanes, L. A., and Cats, A. (1980) Stabilization of the classical pathway C3 convertase C42, by a factor F-42, isolated from serum of patients with systemic lupus erythematosus. Immunology 40, 417-424.
36. Fujita, T., Sumita, T., Yoshida, S., Ito, S., and Tamura, N. (1987) C4 nephritic factor in a patient with chronic glomerulonephritis. J. Clin. Lab. Immunol. 22, 65-70.
37. Tanuma, Y., Ohi, H., Watanabe, S., Seki, M., and Hatano, M. (1989) C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis. Clin. Exp. Immunol. 76, 82-85.
38. Gigli, I., Sorvillo, J., and Halbwachs Mecarelli, L. (1985) Regulation and deregulation of the fluid-phase classical pathway C3 convertase. J. Immunol. 135, 440-444.
39. Ohi, H. and Yasugi, T. (1994) Occurrence of C3 nephritic factor and C4 nephritic factor in membranoproliferative glomerulonephritis (MPGN). Clin. Exp. Immunol. 95, 316-321.
40. Sakari Jokiranta, T., Solomon, A., Pangburn, M. K., Zipfei, P. F., and Meri, S. (1999)Nephritogenic λ light chain dimer: a unique human miniautoantibody against complement Factor H. J. Immunol. 163, 4590-4596.
41. He, H. and Lin, Y-L. (1998) In vitro stimulation of C1s-presenting autoantibodies from patients with systemic lupus erythematosus. J. Immunol. 160, 4641-4647
42. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-686.